{"abstract": "The deal to acquire the specialty drug maker Rottapharm is expected to bolster Meda\u2019s consumer health care business.", "web_url": "https://dealbook.nytimes.com/2014/07/31/meda-to-pay-3-billion-to-acquire-italian-drug-maker/", "snippet": "The deal to acquire the specialty drug maker Rottapharm is expected to bolster Meda\u2019s consumer health care business.", "lead_paragraph": "LONDON \u2013 The Swedish drug maker Meda said on Thursday that it had agreed to pay about $3 billion in cash and stock for the family-owned Italian drug maker Rottapharm, less than a month after that company pulled its plans for an initial public offering.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/29/business/dbpix-meda/dbpix-meda-articleLarge.jpg", "height": 157, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/04/29/business/dbpix-meda/dbpix-meda-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 157}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/29/business/dbpix-meda/dbpix-meda-jumbo.jpg", "height": 269, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/29/business/dbpix-meda/dbpix-meda-superJumbo.jpg", "height": 537, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/29/business/dbpix-meda/dbpix-meda-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/04/29/business/dbpix-meda/dbpix-meda-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/04/29/business/dbpix-meda/dbpix-meda-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Meda to Buy Italian Drug Maker Rottapharm for About $3 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Meda AB", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Mylan Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Rottapharm SpA", "rank": 5, "major": "N"}], "pub_date": "2014-07-31T10:07:51+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/238de1f7-8539-568d-83f0-8bf4960fe2c6", "word_count": 380, "uri": "nyt://article/238de1f7-8539-568d-83f0-8bf4960fe2c6"}